PCL2通过调控PRC2组分影响胶质瘤细胞增殖
该研究利用TCGA数据库和117例临床胶质瘤(WHO I-IV)标本检测PCL2表达,并在U87/U251胶质瘤细胞中通过过表达和干扰PCL2,结合CCK8、集落形成、EdU、细胞周期与凋亡及Western blot实验,发现PCL2在胶质瘤中高表达并促进增殖,同时改变PRC2核心蛋白及组蛋白甲基化水平。
要点
- PCL2在胶质瘤中高表达,TCGA与117例临床标本免疫组化结果一致。
- 过表达PCL2促进U87/U251增殖、集落形成并增加S期细胞。
- PCL2上调EZH2和EED、降低SUZ12,并改变H3K27me3、H3K4me2、H3K9me2水平。
核心结论
- PCL2作为PRC2重要辅助蛋白,可改变PRC2组分表达及组蛋白甲基化水平,可能是调控PRC2成员协同作用的重要枢纽,并作为胶质瘤研究的新靶点。
研究设计与样本
- 研究利用TCGA数据库检测PCL2在多种肿瘤中的表达,并收集117例临床胶质瘤(WHO I-IV)标本行免疫组化检测PCL2表达与定位。
- 在胶质瘤细胞U87/U251中感染过表达和干扰PCL2,采用CCK8、集落形成、EdU、细胞周期和凋亡实验检测增殖与凋亡。
- 用Western blot检测PRC2相关核心蛋白表达,并在DZNeP干预后再次检测PRC2蛋白表达以探讨PCL2作用机制。
主要发现
- TCGA数据库结果和免疫组化染色结果提示PCL2在胶质瘤中高表达。
- PCL2基因促进肿瘤细胞增殖、增强集落形成能力并增加细胞周期S期。
- 过表达PCL2上调EZH2和EED(PRC2两个核心成员)表达、降低SUZ12表达、增加H3K27me3和H3K4me2水平并降低H3K9me2水平;干扰PCL2结果相反。
临床怎么用
- PCL2在胶质瘤中高表达且促进增殖,可作为潜在研究靶点,但尚未提供临床治疗推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Polycomb group (PcG) is an important family of transcriptional regulators that controls growth and tumorigenesis. The PcG mainly consists of two complexes, PRC1 and Polycomb Repressive Complex 2 (PRC2). Polycomb-like 2 (PCL2) is known to interact with the PRC2 protein. The role of PCL2 in the development and progression of glioma is unclear. METHODS: We use The Cancer Genome Atlas (TCGA) database to detect the expression of PCL2 in various tumors. 117 cases of clinical glioma (WHOI-IV) were collected, and PCL2 expression and localization were detected by immunohistochemical staining. Glioma cells U87/U251 were infected with overexpressed and interfered PCL2. CCK8 assay, colony formation assay, EdU method, cell cycle and apoptosis were used to detect cell proliferation and apoptosis. Western blot was used to detect the expression of PRC2-related core proteins. After DZNeP intervention, PRC2 protein expression was again measured to discuss the mechanism of PCL2 action. RESULTS: TCGA database results and immunohistochemical staining results suggest that PCL2 is highly expressed in gliomas. We found that the PCL2 gene promoted tumor cell proliferation, enhanced the colony formation ability, and increased S phase in the cell cycle. The overexpression of PCL2 upregulated the expression levels of EZH2 and EED (two core members of PRC2), decreased the expression of SUZ12, increased the level of H3K27 trimethylation (H3K27me3), H3K4 dimethylation (H3K4me2), and decreased H3K9 dimethylation (H3K9me2). The result after interfering with PCL2 was the opposite. CONCLUSIONS: As an important accessory protein of PRC2, PCL2 can not only change the expression of PRC2 components, but also affect the expression level of Histone methylation. Therefore, PCL2 may be an important hub for regulating the synergy among PRC2 members. This study revealed PCL2 as a new target for tumor research and open up a new avenue for future research in glioma.
引用
- Wang F, Gao Y, Lv Y, et al. Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells. J Neurooncol. 2020. PMID: 32436117. doi:10.1007/s11060-020-03538-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。